Australia's largest stock trading and investment forum Australia's #1 stock forum

AC8

Click for more information

0.00%

4.0¢ auscann group holdings ltd

Hi, Regarding last year's presentation, comercialisation of...

First 15 Last

Share
Profile

Follow
Nauschder

60 Posts.

7

03/02/22

02:06

Post #: 59316192
Share

Hi,

Originally posted by amb005: ↑

Notice that I said they are averaging 2 million cash burn a quarter, so ofcourse doesnt mean every quarter. This is the average. If your relying on a R&D Credit to make your finances look good, then I think your perspective on what a good business is might be a little skewed.

Funny you say Im set in my views, my "views" are just maths on the financial statements, lol, hardly subjective views when its factual and maths from quarterlies, you on the other hand have clearly bought the new story, they might be able to turn it around, who knows, lets see if it pans out.

Expand

Regarding last year's presentation, comercialisation of dermacan will start early in 2022 in the United States and South Africa.
What does the board think, will this (combined with reducing the cash burn) move AusCann to a positive cash flow?
My hope is still CPAT1 but this will still take years.

Cheers
Nauscher

AC8 Price at posting: 7.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 8 more messages in this thread...

First 15 Last

Add AC8 (ASX) to my watchlist